Global Single-cell Omics Market: Introduction

Single cell genome-wide approaches provide a valuable opportunity to measure different molecules, such as DNA, RNA, protein, and chromatin with ultimate resolution. Utilizing these different single cell omics profiling strategies as building blocks, we can construct a multi-omics profile for the same cell. Development of high-throughput next-generation sequencing technology has enabled multiomics analysis at single-cell resolution. Single-cell multiomics would also enhance our understanding of the cellular properties and population architectures of heterogeneous tissues and provide snapshots of the interplay between these multiomics molecular layers and the complexity encompassing every level of biological organization. Single-cell omics are becoming increasingly prevalent, owing to continuous technological improvements and they contribute to the discovery of new and rare cell types as well as deciphering of disease pathogenesis and outcome. Single-cell omics have great potential in deciphering virus biology and virus-host cell interactions, and are a powerful tool in virology that should be applied more often in the future.

Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Single-cell Omics Market Report

Key Drivers of Global Single-cell Omics Market

Technological Advancements in Single-cell Analysis Products

New advances of single-cell technologies are facilitating the opportunity to discern biological insights within individual cells. Single-cell technologies can be crudely split between those that enable single-cell separation and those that enable single-cell analysis. From the cell separation perspective, new approaches that isolate single living cells from a fluid sample; manipulate cells for image-based selection; utilize infrared laser capture; and those that compartmentalize individual cells into picoliter droplets are of great interest. New single-cell platforms facilitate separation and analysis, and in some cases both the potential development of these technologies and their limitations are rapidly being developed and are proving of increasing interest to researchers, particularly in the area of single cell genomics.

Growing Biotechnology and Biopharmaceutical Industries

Large-scale biotech-manufacturing facilities require US$ 200 Mn to US$ 500 Mn or more to build, compared with similar-scale small-molecule facilities that may cost just US$ 30 Mn to US$ 100 Mn. Rapid growth and increasing importance of the industry is producing new challenges and opportunities. Biopharma players must revisit and fundamentally reassess many of the strategies, technologies, and operational approaches they currently use in order to keep pace.

North America to Account for Major Share of Global Single-cell Omics Market

  • North America is projected to account for a major share of the global single-cell omics market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the near future, primarily due to availability of developed health care infrastructure and continuous research activities for the development of advanced technologies in the region. North America is expected to be followed by Europe during the forecast period.
  • The single-cell omics market in Asia Pacific is expected to expand at a high CAGR during the forecast period. This can be attributed to rise in trend of preventive health care measures in the region.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Single-cell Omics Market Report

Key Players Operating in Global Market

The global single-cell omics market is highly consolidated, with the presence of a small number of key players. Several manufacturers hold a major share of the market in their respective regions. Leading players operating in the global single-cell omics market are:

  • 10x Genomics, Inc.
  • 1CellBio
  • MissionBio
  • NanoString Technologies, Inc.
  • Fluidigm Corporation
  • Fluxion Biosciences
  • Bio-Rad Laboratories, Inc.
  • Celsee, Inc.
  • BGI Genomics Co. Ltd.
  • GE LifeSciences
  • Illumina, Inc.
  • Takara Bio
  • QIAGEN N.V.

Global Single-cell Omics Market: Research Scope

Global Single-cell Omics Market, by Product Type

  • Single Cell Genomics
  • Single Cell Proteomics
  • Single Cell Transcriptomics
  • Single Cell Metabolomics

Global Single-cell Omics Market, by Application

  • Oncology
  • Cell Biology
  • Neurology
  • Immunology
  • Others

Global Single-cell Omics Market, by End-user

  • Academic & Research Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Others

Global Single-cell Omics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Single Cell Omics Market

Pre Book